May 2018 FDA Recall Piperacillin And Tazobactam by Auromedics Pharma Llc
D-0926-2018 - Presence of Particulate Matter
This Class I drug recall was voluntarily initiated by Auromedics Pharma Llc on May 1, 2018 for the product Piperacillin And Tazobactam. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0926-2018
Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
05-01-2018
05-23-2018
77,400 vials
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
AuroMedics Pharma LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA
06-21-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30
Batch or Lot Expiration Information
Lot# s: PP0317061-A, PP0317049-A; EXP August 2019